(Hypertension. 1995;25:570-580.)
© 1995 American Heart Association, Inc.
Articles |
Differential Gene Expression of Renin and Angiotensinogen in the TGR(mREN-2)27 Transgenic Rat
From the Max-Delbrück-Center for Molecular Medicine, Berlin-Buch, Germany (M.A.L., M. Böhm, J.B., M. Bader, D.G.); Department of Pharmacology, Osaka City (Japan) University Medical School (S.K.); and the Department of Anatomy I, University of Heidelberg (Germany) (S.B.).
Abstract Transgenic rats carrying the murine Ren-2 gene represent a monogenetic model of hypertension characterized by low plasma renin and high extrarenal expression of the transgene. The hypothesis has been raised that stimulated local renin-angiotensin systems may be responsible for the development of hypertension in this model. This study analyzes the effects of the converting enzyme inhibitor lisinopril, which specifically interferes with the renin-angiotensin system, and the direct vasodilator dihydralazine on the renal and extrarenal expression of renin and angiotensinogen. A comparison of gene expression between heterozygous and homozygous transgenic and normal Sprague-Dawley rats was also performed. We demonstrate high sensitivity of blood pressure toward converting enzyme inhibition in transgenic TGR(mREN-2)27 rats. In the kidney, expression of the transgene and the endogenous renin gene increased, suggesting that both are modulated by lisinopril in a similar manner. On the other hand, blood pressure reduction by dihydralazine did not abolish renal renin suppression in transgenic rats, indicating that mechanisms different from direct effects of blood pressure account for renin suppression. Homozygosity for the transgene led to increased Ren-2 expression and higher blood pressure and had opposite effects on angiotensinogen expression compared with heterozygous rats. Cardiac hypertrophy was reduced by lisinopril but not dihydralazine and was positively correlated with cardiac angiotensinogen expression. Increased angiotensin II in the adrenal gland of TGR(mREN-2)27 rats, which overexpresses the transgene, provides evidence that this leads to enhanced generation of tissue angiotensin II. We conclude that expression of the mouse transgene, the endogenous rat renin gene, and the angiotensinogen gene is subject to differential tissue-specific regulation. Reversal of cardiovascular damage with the converting enzyme inhibitor but not dihydralazine suggests that angiotensin II generated locally may be involved in the pathogenesis of hypertension and structural changes in TGR(mREN-2)27 rats.
Key Words: rats, transgenic • renin-angiotensin system • hypertension, experimental • gene expression
This article has been cited by other articles:
 |
|
 |
|
  A. Whaley-Connell, J. Habibi, S. A. Cooper, V. G. DeMarco, M. R. Hayden, C. S. Stump, D. Link, C. M. Ferrario, and J. R. Sowers Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E103 - E109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Henriksen Improvement of insulin sensitivity by antagonism of the renin-angiotensin system Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R974 - R980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Sloniger, V. Saengsirisuwan, C. J. Diehl, B. B. Dokken, N. Lailerd, A. M. Lemieux, J. S. Kim, and E. J. Henriksen Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1074 - E1081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Vongvatcharanon, S. Vongvatcharanon, N. Radenahmad, P. Kirirat, P. Intasaro, P. Sobhon, and T. Parker Angiotensin II may mediate apoptosis via AT1-receptors in the rat cardiac conduction system Journal of Renin-Angiotensin-Aldosterone System, September 1, 2004; 5(3): 135 - 140. [Abstract] [PDF]
|
|
|
|
|
|
M. Kurdi, C. Cerutti, J. Randon, L. McGregor, and G. Bricca Macroarray analysis in the hypertrophic left ventricle of renin-dependent hypertensive rats: identification of target genes for renin Journal of Renin-Angiotensin-Aldosterone System, June 1, 2004; 5(2): 72 - 78. [Abstract] [PDF]
|
|
|
|
 |
|
 T. M. Seccia, A. S. Belloni, R. Kreutz, M. Paul, G. G. Nussdorfer, A. C. Pessina, and G. P. Rossi Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II J. Am. Coll. Cardiol., February 19, 2003; 41(4): 666 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Peters, R. Farrenkopf, S. Clausmeyer, J. Zimmer, S. Kantachuvesiri, M. G.F. Sharp, and J. J. Mullins Functional Significance of Prorenin Internalization in the Rat Heart Circ. Res., May 31, 2002; 90(10): 1135 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Zolk, J. Quattek, U. Seeland, A. El-Armouche, T. Eschenhagen, and M. Bohm Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats Cardiovasc Res, February 1, 2002; 53(2): 363 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bolon and E. Galbreath Use of Genetically Engineered Mice in Drug Discovery and Development: Wielding Occam's Razor to Prune the Product Portfolio International Journal of Toxicology, January 1, 2002; 21(1): 55 - 64. [Abstract] [PDF]
|
|
|
|
|
|
J. E. Bishop, L. A. Kiernan, H. E. Montgomery, P. Gohlke, and J. R. McEwan Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats Cardiovasc Res, July 1, 2000; 47(1): 57 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kim and H. Iwao Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Lee-Kirsch, F. Gaudet, M. C. Cardoso, and K. Lindpaintner Distinct Renin Isoforms Generated by Tissue-Specific Transcription Initiation and Alternative Splicing Circ. Res., February 5, 1999; 84(2): 240 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Jacinto, J. J. Mullins, and K. D. Mitchell Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats Am J Physiol Renal Physiol, February 1, 1999; 276(2): F315 - F322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Zolk, M. Flesch, G. Nickenig, P. Schnabel, and M. Bohm Alteration of intracellular Ca2+-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats Cardiovasc Res, July 1, 1998; 39(1): 242 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bohlender, J. Menard, O. Edling, D. Ganten, and F. C. Luft Mouse and rat plasma renin concentration and gene expression in (mRen2)27 transgenic rats Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1450 - H1456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Springate, L. G. Feld, and D. Ganten Enalapril and Renal Function in Hypertensive Rats Transgenic for Mouse Renin Gene Hypertension, October 1, 1997; 30(4): 868 - 872. [Abstract] [Full Text]
|
|
|
|
|
|
W. R. Dunn and S. M. Gardiner Differential Alteration in Vascular Structure of Resistance Arteries Isolated From the Cerebral and Mesenteric Vascular Beds of Transgenic [(mRen-2)27], Hypertensive Rats Hypertension, May 1, 1997; 29(5): 1140 - 1147. [Abstract] [Full Text]
|
|
|
|
|
|
K. Ohta, S. Kim, and H. Iwao Role of Angiotensin-Converting Enzyme, Adrenergic Receptors, and Blood Pressure in Cardiac Gene Expression of Spontaneously Hypertensive Rats During Development Hypertension, October 1, 1996; 28(4): 627 - 634. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Ohta, S. Kim, H. Wanibuchi, D. Ganten, and H. Iwao Contribution of Local Renin-Angiotensin System to Cardiac Hypertrophy, Phenotypic Modulation, and Remodeling in TGR(mRen2)27 Transgenic Rats Circulation, August 15, 1996; 94(4): 785 - 791. [Abstract] [Full Text]
|
|
|
|
|
|
M. W. Thompson, S. B. Smith, and C. D. Sigmund Regulation of Human Renin mRNA Expression and Protein Release in Transgenic Mice Hypertension, August 1, 1996; 28(2): 290 - 296. [Abstract] [Full Text]
|
|
|
|
|
|
M. F. Callahan, P. Li, C. M. Ferrario, D. Ganten, and M. Morris Salt-Sensitive Hypertension in (mREN-2)27 Transgenic Rats Hypertension, March 1, 1996; 27(3): 573 - 577. [Abstract] [Full Text]
|
|